Alexius John
@dralexiusj
Medical Oncology Clinical Research Fellow
@RoyalMarsdenHospital Lung Unit 🇦🇺🇬🇧...and avid Gooners supporter
ID: 1670715474403897344
19-06-2023 08:50:09
28 Tweet
42 Followers
53 Following
.Aɴᴛᴏɴɪᴏ Pᴀssᴀʀᴏ presents MARIPOSA2. Increased heme tox for ALC arm. Both Ix improved PFS & ORR. icPFS unexpt benefit or both arms clear for ami-chemo. Lazer adding little to brain. OS too early. Ami-chemo better tox than ALC. Ami-chemo a new SoC option over chemo alone #ESMO23
Superb case studies presented by our young oncologists during this ESMO Lung preceptorship, always a great time for sharing! ESMO - Eur. Oncology
Thanks for the mentorship and support Jarushka Naidoo and Ronan Andrew McLaughlin A complex topic, hopefully patients and physicians can refer to this paper in a challenging and common clinical conundrum
Come check out our poster on Lorlatinib associated weight gain and dyslipidaemia at #ELCC2024, important toxicities to recognise and communicate to patients! Sanjay Popat David McMahon
Excellent first day at BTOG 2024 in Belfast chaired by the one and only Sanjay Popat! Looking forward to more great talks. Come check out our posters on real world outcomes of a genomic tumour advisory board in lung cancer, and of immunotherapy in mesothelioma! #BTOG24 #Belfast
Awesome to be at #BTOG24 with our spectacular & dynamic Lung team from The Royal Marsden NHS Foundation Trust The Royal Marsden Cancer Charity #ItTakesAVillage
Pressure on CNS service = commonest reason why diagnostic ctDNA not undertaken Important consideration when setting up this routine service Great work fromSandra Wakelin and Dr Riyaz Shah #BTOG24 #LCSM
Excellent talks by Will Ricketts 💙 🕊️, Yvonne Summers and Michelle Rosario on the NHS England ctDNA transformation project and how it has made a difference for our patients. Privileged to be a part of this pivotal initiative! #BTOG24
jtocrr.org/article/S2666-… Thanks to JTO & JTO CRR for publishing this informative case report illustrating successful rechallenge of lorlatinib after grade 4 psychosis from our team The Royal Marsden NHS Foundation Trust led by Alexius John and Sanjay Popat
Honored to be ASCO #FeaturedVoice! UAB O'Neal Comprehensive Cancer Center Will discuss data on #lcsm, and #phase1 along these fantasitic folks! Fumiko Ladd Chino, MD, FASCO Jill Feldman @jacobadashek Ana I. Velázquez Mañana, MD, MSc, FASCO Ramy Sedhom, MD, FASCO Rafeh Naqash, MD Devika Das, MD, MSHQS, FASCO Oncology Brothers TwoOncDocs Herbert Loong, MBBS, FASCO 👇 #lcsm abstracts!
.JessicaJLinMD discusses CROWN and summarizes 1st line lorli is now the preferred option. Have to say I agree. Great if Pfizer Inc. and NICE can agree to allow UK patients to access lorli 1st line. #ASCO24 BTOG
How should the results of LAURA CNS/distant mets data be interpreted? Check out our editorial published in Annals of Oncology Sanjay Popat Fiona McDonald: kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F%2…
Check out our retrospective analysis on lorlatinib associated weight gain and dyslipidaemia now available in Lung Cancer: lungcancerjournal.info/article/S0169-… Sanjay Popat David McMahon
Delighted to share this review “Navigating the landscape of immune checkpoint inhibitors and novel immunotherapies in melanoma: long-term outcomes, progress, and challenges” from the renal and skin units The Royal Marsden NHS Foundation Trust tandfonline.com/doi/full/10.10…
Yes, Lord's Cricket Ground again for D4 of this amazing #INDvsENG match. Discussing all things cricket with superb RMH fellows and future leaders David Cheng, Harriet McGrath Alexius John. Sadly no sight of my cricket sparring partner Clive Peedell